학술논문
POSTER: CT-045 Primary Results From OUTREACH: A Phase II Study of Lisocabtagene Maraleucel (Liso-Cel) Administered in the Community Setting as Outpatient or Inpatient Treatment in Patients With Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Document Type
Abstract
Author
Linhares, Yuliya; Freytes, Cesar; Cherry, Mohamad; Bachier, Carlos; Maris, Michael; Hoda, Daanish; Varela, Juan C.; Bellomo, Courtney; Cross, Scott; Essell, James; Fanning, Suzanne; Terebelo, Howard; Yimer, Habte; Courtright, Jay; Sharman, Jeff P.; Kostic, Ana; Vedal, Min; Ogasawara, Ken; Avilion, Ariel; Espinola, Ricardo; Yuan, Brenda; Mattar, Bassam
Source
In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S233-S233
Subject
Language
ISSN
2152-2650